US Inventor, Inc. v. United States Patent and Trademark Office

District Court, District of Columbia·Decided July 12, 2023·No. Civil Action No. 2022-2218·Published

Opinion

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

US INVENTOR, INC. et al., Plaintiffs, v. Civil Action No. 22-2218 (JDB)

UNITED STATES PATENT AND TRADEMARK OFFICE et al., Defendants.

MEMORANDUM OPINION

Plaintiffs US Inventor, Inc. and National Small Business United (“NSBU”) bring this action against defendants the U.S. Patent and Trademark Office (“USPTO”) and Katherine Vidal, the Under Secretary of Commerce for Intellectual Property and Director of the USPTO, alleging that defendants violated the Administrative Procedure Act (“APA”) by denying plaintiffs’ rulemaking petition. Defendants move to dismiss the case, arguing that plaintiffs lack standing. For the reasons set forth herein, the Court concludes that plaintiffs lack standing and will accordingly grant defendants’ motion to dismiss on that basis.

Background

In 2011, Congress passed the America Invents Act (“AIA”), which established the Patent Trial and Appeals Board (“PTAB”) within the USPTO. Compl. for Decl. & Injunctive Relief [ECF No. 1] (“Compl.”) ¶ 18; see 35 U.S.C. § 6. The AIA vested authority in the PTAB to conduct various proceedings by which the validity of patents may be challenged, including inter partes review (“IPR”) and post-grant review (“PGR”) proceedings (together, “AIA trials”). See Compl. ¶ 18; 35 U.S.C. § 6(b).

The IPR and PGR processes begin when “a person who is not the owner of a patent” files a petition with the USPTO challenging the patent and requesting that an AIA trial take place.

35 U.S.C. §§ 311(a), 321(a). When a petition is filed, the Director of the USPTO decides whether to institute an AIA trial. Id. §§ 324(b), 314(c). “The Director may not authorize an inter partes review to be instituted unless the Director determines that . . . there is a reasonable likelihood that the [patent challenger] would prevail with respect to at least 1 of the claims challenged in the petition.” Id. § 314(a); see also id. § 324(a) (“The Director may not authorize a post-grant review to be instituted unless . . . it is more likely than not that at least 1 of the claims challenged in the petition is unpatentable.”). No equivalent statutory mandate exists that dictates when a Director must institute a trial: even if a patent challenger makes the required showing that a patent is likely invalid, the Director may still, in her discretion, decide not to institute an AIA trial. See Compl. ¶ 19 (“The AIA set only a one-sided (prohibitory) bound on the Director’s authority . . . .”); Cuozzo Speed Techs., LLC v. Lee, 579 U.S. 261, 273 (2016) (“[T]he agency’s decision to deny a petition is a matter committed to the Patent Office’s discretion.”).

If the Director decides not to institute review, that decision is “final and nonappealable.”

35 U.S.C. §§ 314(d), 324(e). But a disgruntled patent challenger has a second avenue to challenge a patent: challenges to a patent’s validity may be brought in U.S. District Court either instead of an AIA petition or following the Director’s decision not to institute an AIA trial. See Credit Acceptance Corp. v. Westlake Servs., 859 F.3d 1044, 1052–53 (Fed. Cir. 2017).

Congress did cabin the Director’s discretion to decline to institute an AIA trial in one important way: 35 U.S.C. §§ 316 and 326 require that “the Director . . . prescribe regulations . . . setting forth the standards for the showing of sufficient grounds to institute” an AIA trial. Compl. ¶ 26 (cleaned up) (quoting 35 U.S.C. §§ 316(a), 326(a)). The USPTO has accordingly designated “as precedential or informative certain cases that identify considerations for the Board’s exercise of the Director’s discretion over the institution decision.” Defs.’ Mot. to Dismiss [ECF No. 6] (“Mot. to Dismiss”) at 5. “The principles announced in some of those cases have also been

incorporated into a Consolidated Trial Practice Guide.” Id. at 6. And in October 2020, the Director “issued a request for comments seeking the public’s view on ‘considerations for instituting trials’ before the Board under the AIA.” Id.; see also Ex. B to Compl. [ECF No. 1-2] (“USPTO Decision”) at 2.

Plaintiffs’ position is that the USPTO’s approach to providing guidelines—designating some opinions “precedential” or “informative” without putting those considerations through notice-and-comment rulemaking—is unlawful. See Compl. ¶¶ 32–36 (describing this approach as an “end-run[]” around the APA and “extra-regulatory”). 1 US Inventor expressed that same position in a lawsuit it filed in 2021 in the U.S. District Court for the Eastern District of Texas. See US Inventor Inc. v. Hirshfeld, 549 F. Supp. 3d 549, 553 (E.D. Tex. 2021) (“Plaintiffs generally allege that the Director’s designation of such decisions as precedential constitutes unlawful rulemaking without the formal notice and comment required under the Administrative Procedures Act (‘APA’), 5 U.S.C. § 553.”), aff’d sub nom. US Inventor Inc. v. Vidal, No. 21-40601, 2022 WL 4595001 (5th Cir. Sept. 30, 2022), and appeal dismissed No. 2021-2212, 2022 WL 17246329 (Fed. Cir. Nov. 28, 2022). That case—which will be discussed throughout this Opinion—was dismissed for lack of standing in July 2021, id. at 559, a decision which was affirmed by the Fifth Circuit in September 2022, US Inventor Inc. v. Vidal, No. 21-40601, 2022 WL 4595001, at *7 (5th Cir. Sept. 30, 2022).

On August 27, 2020, following the dismissal of the Eastern District of Texas case, US Inventor and NSBU jointly filed a petition for rulemaking with the USPTO under 5 U.S.C. § 553(e). Compl. ¶ 13; see Ex. A to Compl. [ECF No. 1-1] (“Petition”). The petition proposed a

1 Although plaintiffs’ well-pleaded allegations are taken as true at the motion to dismiss stage, the Court need not accept “legal conclusions cast in the form of factual allegations,” which many of plaintiffs’ allegations in this section of their complaint are. Browning v. Clinton, 292 F.3d 235, 242 (D.C. Cir. 2002) (internal quotation marks omitted).

rule establishing a series of criteria the USPTO would use when deciding whether to institute an AIA trial. 2 Compl ¶ 13; see Petition at 12–14. On October 19, 2021, defendants denied the petition. Compl. ¶ 14; see USPTO Decision at 3. The USPTO stated that it, “in principle, supports the goal of providing clarity as to institution standards for AIA trials” and accordingly had requested “feedback from stakeholders on the current practices of the Patent Trial and Appeal Board in exercising discretion not to institute an AIA trial proceeding.” USPTO Decision at 2. And because “[t]he issues raised in the Petition overlap [with] those raised in the” request for comments, it “denie[d] the Petition, with the understanding that suggestions provided in the Petition w[ould] be considered as part of any future rulemaking on AIA trials.” Id. at 3.

Plaintiffs challenge this denial. Their complaint alleges a violation of the APA, 5 U.S.C.

§§ 553, 555, and 706. Compl. ¶¶ 46–62. There are a few dimensions to their claim. First, plaintiffs claim that the USPTO violated § 555(b)’s procedural requirement “that ‘within a reasonable time, each agency shall proceed to conclude a matter presented to it,’” id. ¶ 52 (quoting § 555(b)), by stating that plaintiffs’ rulemaking suggestions “would be considered only in unspecified ‘future rulemaking on AIA trials,’” id. ¶ 62. Section 706 allows enforcement of this requirement by “requir[ing] [courts] to ‘compel agency action unlawfully withheld or unreasonably delayed.’” Id. ¶ 47 (quoting § 706(1)).

Plaintiffs also challenge the denial of the petition under § 555(e), which requires that the USPTO provide notice of the denial and that such notice “shall be accompanied by a brief statement of the grounds for denial.” Compl. ¶ 53 (quoting § 555(e)). According to plaintiffs, “[t]he USPTO’s reasoning that it will not presently commence with rulemaking because it may

2 The petition also suggested a rule defining “privy,” see Petition at 12, which is not at issue in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

US Inventor, Inc. v. United States Patent and Trademark Office, (D.D.C. 2023).

US Inventor, Inc. v. United States Patent and Trademark Office (US Inventor, Inc. v. United States Patent and Trademark Office) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

City of Los Angeles v. Lyons
461 U.S. 95 (Supreme Court, 1983)
Lujan v. Defenders of Wildlife
504 U.S. 555 (Supreme Court, 1992)
Gettman v. Drug Enforcement Administration
290 F.3d 430 (D.C. Circuit, 2002)
National Taxpayers Union, Inc. v. United States
68 F.3d 1428 (D.C. Circuit, 1995)
Clapper v. Amnesty International USA
133 S. Ct. 1138 (Supreme Court, 2013)
Sierra Club v. Environmental Protection Agency
754 F.3d 995 (D.C. Circuit, 2014)
Joseph Arpaio v. Barack Obama
797 F.3d 11 (D.C. Circuit, 2015)
Humane Society of the United States v. Vilsack
797 F.3d 4 (D.C. Circuit, 2015)
Food & Water Watch, Inc. v. Thomas Vilsack
808 F.3d 905 (D.C. Circuit, 2015)
Cuozzo Speed Technologies, LLC v. Lee
579 U.S. 261 (Supreme Court, 2016)
Ramon Cierco v. Steven Mnuchin
857 F.3d 407 (D.C. Circuit, 2017)
Credit Acceptance Corp. v. Westlake Services
859 F.3d 1044 (Federal Circuit, 2017)